Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
$30.16
+0.6%
$29.77
$28.25
$35.61
$67.31B0.554.91 million shs3.01 million shs
Cyclacel Pharmaceuticals, Inc. stock logo
CYCC
Cyclacel Pharmaceuticals
$2.32
+10.0%
$2.16
$1.30
$13.20
$3.06M0.54650,940 shs325,517 shs
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
$11.11
$11.16
$9.90
$11.98
$36.77MN/A7,280 shs2 shs
NXG NextGen Infrastructure Income Fund stock logo
NXG
NXG NextGen Infrastructure Income Fund
$40.80
-1.8%
$38.81
$30.32
$42.29
N/AN/A25,493 shs14,183 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
+0.02%+1.84%+1.18%+1.84%-15.51%
Cyclacel Pharmaceuticals, Inc. stock logo
CYCC
Cyclacel Pharmaceuticals
+1.93%-0.47%+0.48%-9.44%-74.35%
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
0.00%0.00%0.00%0.00%+4.81%
NXG NextGen Infrastructure Income Fund stock logo
NXG
NXG NextGen Infrastructure Income Fund
+3.83%+4.77%+1.17%+18.35%+24.92%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
2.1633 of 5 stars
0.05.02.50.02.70.01.3
Cyclacel Pharmaceuticals, Inc. stock logo
CYCC
Cyclacel Pharmaceuticals
1.7 of 5 stars
3.33.00.00.02.90.00.6
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
N/AN/AN/AN/AN/AN/AN/AN/A
NXG NextGen Infrastructure Income Fund stock logo
NXG
NXG NextGen Infrastructure Income Fund
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
2.67
Moderate BuyN/AN/A
Cyclacel Pharmaceuticals, Inc. stock logo
CYCC
Cyclacel Pharmaceuticals
2.50
Moderate Buy$11.00374.14% Upside
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
N/AN/AN/AN/A
NXG NextGen Infrastructure Income Fund stock logo
NXG
NXG NextGen Infrastructure Income Fund
N/AN/AN/AN/A

Current Analyst Ratings

Latest NXG, BTI, GSD, RLM, and CYCC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/3/2024
Cyclacel Pharmaceuticals, Inc. stock logo
CYCC
Cyclacel Pharmaceuticals
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$21.00 ➝ $11.00
(Data available from 5/8/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
$33.94B1.98$18.97 per share1.59$26.80 per share1.13
Cyclacel Pharmaceuticals, Inc. stock logo
CYCC
Cyclacel Pharmaceuticals
$420K7.28N/AN/A$0.57 per share4.07
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
N/AN/AN/AN/A($1.84) per shareN/A
NXG NextGen Infrastructure Income Fund stock logo
NXG
NXG NextGen Infrastructure Income Fund
$-28.13MN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
-$17.87BN/A0.005.981.25N/AN/AN/AN/A
Cyclacel Pharmaceuticals, Inc. stock logo
CYCC
Cyclacel Pharmaceuticals
-$22.56M-$27.22N/AN/AN/AN/A-448.19%-151.29%5/9/2024 (Estimated)
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
-$790KN/A0.00N/AN/AN/A-2.30%N/A
NXG NextGen Infrastructure Income Fund stock logo
NXG
NXG NextGen Infrastructure Income Fund
N/A-$0.24N/AN/AN/AN/AN/AN/A

Latest NXG, BTI, GSD, RLM, and CYCC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/19/2024Q4 2023
Cyclacel Pharmaceuticals, Inc. stock logo
CYCC
Cyclacel Pharmaceuticals
-$6.35-$6.23+$0.12-$6.23N/A$0.03 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
$2.909.62%+1.45%N/A1 Years
Cyclacel Pharmaceuticals, Inc. stock logo
CYCC
Cyclacel Pharmaceuticals
N/AN/AN/AN/AN/A
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
N/AN/AN/AN/AN/A
NXG NextGen Infrastructure Income Fund stock logo
NXG
NXG NextGen Infrastructure Income Fund
$5.6713.90%+0.29%N/A 1 Years

Latest NXG, BTI, GSD, RLM, and CYCC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/14/2024
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
quarterly$0.74319.6%12/20/202412/20/20242/6/2025
2/13/2024
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
quarterly$0.74319.6%12/20/202412/20/20242/6/2025
2/12/2024
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
quarterly$0.74319.5%6/28/20246/28/20248/7/2024
2/8/2024
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
Quarterly$0.73309.53%3/21/20243/22/20245/7/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
0.67
0.91
0.59
Cyclacel Pharmaceuticals, Inc. stock logo
CYCC
Cyclacel Pharmaceuticals
N/A
0.91
0.91
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
N/A
0.01
0.01
NXG NextGen Infrastructure Income Fund stock logo
NXG
NXG NextGen Infrastructure Income Fund
N/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
46,0002.23 billion2.23 billionOptionable
Cyclacel Pharmaceuticals, Inc. stock logo
CYCC
Cyclacel Pharmaceuticals
2,0181.32 million1.21 millionOptionable
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
N/A3.31 million1.23 millionNot Optionable
NXG NextGen Infrastructure Income Fund stock logo
NXG
NXG NextGen Infrastructure Income Fund
N/AN/AN/AN/A

NXG, BTI, GSD, RLM, and CYCC Headlines

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

British American Tobacco logo

British American Tobacco

NYSE:BTI
British American Tobacco p.l.c. engages in the provision of tobacco and nicotine products to consumers worldwide. It also offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company offers its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Camel, Natural American Spirit, Newport, Vogue, Viceroy, Kool, Peter Stuyvesant, Craven A, State Express 555 and Shuang Xi brands. It also distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.
Cyclacel Pharmaceuticals logo

Cyclacel Pharmaceuticals

NASDAQ:CYCC
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's lead product includes fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and Plogosertib, a polo-like kinase inhibitor program, which is in Phase 1/2 clinical trial for the treatment of advanced leukemias and solid tumors. It has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias. The company was founded in 1996 and is headquartered in Berkeley Heights, New Jersey.
Global System Dynamics logo

Global System Dynamics

NASDAQ:GSD
Global System Dynamics, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company focuses its search on the farming and national security sectors, including farming related operations and businesses that support the farming industry. The company was formerly known as Gladstone Acquisition Corporation. Global System Dynamics, Inc. was incorporated in 2021 and is based in Houston, Texas.
NXG NextGen Infrastructure Income Fund logo

NXG NextGen Infrastructure Income Fund

NYSE:NXG
NXG NextGen Infrastructure Income Fund is a closed ended equity mutual fund launched and managed by Cushing MLP Asset Management, LP. The fund invests in stocks of companies across the energy supply chain spectrum, including upstream, midstream and downstream energy companies, as well as oil and gas services and logistics companies, energy-intensive chemical, metal and industrial and manufacturing companies and engineering and construction companies. NXG NextGen Infrastructure Income Fund was formed in 2012 and is domiciled in the United States.